{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:10:54Z","timestamp":1794579054676,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470826"],"award-info":[{"award-number":["82470826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04441-z","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:31:59Z","timestamp":1762338719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative efficacy and safety of neoadjuvant immunotherapy vs chemotherapy in resectable head and neck squamous cell carcinoma: an umbrella review of randomized controlled trials and single-arm studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Yunfei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"4441_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102337","volume":"12","author":"A Zotta","year":"2024","unstructured":"Zotta A, Marciano ML, Sabbatino F, Ottaiano A, Cascella M, Pontone M, et al. Neoadjuvant immunotherapy in head and neck cancers: a paradigm shift in treatment approach. Biomedicines. 2024;12:2337. https:\/\/doi.org\/10.3390\/biomedicines12102337.","journal-title":"Biomedicines"},{"key":"4441_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106479","volume":"145","author":"S Chen","year":"2023","unstructured":"Chen S, Yang Y, Wang R, Fang J. Neoadjuvant PD-1\/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: meta-analysis. Oral Oncol. 2023;145:106479. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106479.","journal-title":"Oral Oncol"},{"key":"4441_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/JS9.0000000000001891","volume":"111","author":"B Li","year":"2025","unstructured":"Li B, Xie S, Han J, Cao H, Lin Z, Hu H, et al. Neoadjuvant chemoimmunotherapy in resectable locally advanced oral squamous cell carcinoma: a single-center retrospective cohort study. Int J Surg. 2025;111:781\u201390. https:\/\/doi.org\/10.1097\/JS9.0000000000001891.","journal-title":"Int J Surg"},{"key":"4441_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010015","volume":"11","author":"A Karabajakian","year":"2018","unstructured":"Karabajakian A, Gau M, Reverdy T, Neidhardt E-M, Fayette J. Induction chemotherapy in head and neck squamous cell carcinoma: a question of belief. Cancers. 2018;11:15. https:\/\/doi.org\/10.3390\/cancers11010015.","journal-title":"Cancers"},{"key":"4441_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100426","volume":"2","author":"HM Knochelmann","year":"2021","unstructured":"Knochelmann HM, Horton JD, Liu S, Armeson K, Kaczmar JM, Wyatt MM, et al. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021;2:100426. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100426.","journal-title":"Cell Rep Med"},{"key":"4441_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/nejmoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med. 2025;393:37\u201350. https:\/\/doi.org\/10.1056\/nejmoa2415434.","journal-title":"N Engl J Med"},{"key":"4441_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/ohn.867","volume":"171","author":"Y Yu","year":"2024","unstructured":"Yu Y, Chen H, Huang Z, Yuan Z, Liu L, Zhao J, et al. Anti-PD-(L)1-based neoadjuvant therapy in head and neck carcinoma: a meta-analysis of prospective clinical trials. Otolaryngol Head Neck Surg. 2024;171:1321\u201340. https:\/\/doi.org\/10.1002\/ohn.867.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"4441_CR8","unstructured":"Wang L, Chen H, Gong X, Zhang L, Lu Z, Chen X. Analysis and evaluation of the efficacy and safety of neoadjuvant anti-PD-1\/PD-L1 in resectable head and neck squamous cell carcinoma. Chin J Otorhinolaryngol Skull Base Surg. 2024;30(3):233\u2013233. Available at: http:\/\/zgebyheldwkzz.ijournals.cn\/html\/2024\/3\/20240304.htm."},{"key":"4441_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","volume":"38","author":"JH Schiavo","year":"2019","unstructured":"Schiavo JH. PROSPERO: an international register of systematic review protocols. Med Ref Serv Q. 2019;38:171\u201380. https:\/\/doi.org\/10.1080\/02763869.2019.1588072.","journal-title":"Med Ref Serv Q"},{"key":"4441_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4.","journal-title":"Syst Rev"},{"key":"4441_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.178","volume":"3","author":"L Lin","year":"2020","unstructured":"Lin L, Xu C. Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives. Health Sci Rep. 2020;3:e178. https:\/\/doi.org\/10.1002\/hsr2.178.","journal-title":"Health Sci Rep"},{"issue":"1","key":"4441_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01381-z","volume":"21","author":"TH Barker","year":"2021","unstructured":"Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E, et al. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21(1):189. https:\/\/doi.org\/10.1186\/s12874-021-01381-z.","journal-title":"BMC Med Res Methodol"},{"key":"4441_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"key":"4441_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. introduction\u2014grade evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"key":"4441_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071609","author":"Y Huang","year":"2023","unstructured":"Huang Y, Chen Z, Chen B, Li J, Yuan X, Li J, et al. Dietary sugar consumption and health: umbrella review. BMJ. 2023. https:\/\/doi.org\/10.1136\/bmj-2022-071609.","journal-title":"BMJ"},{"key":"4441_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24861-8","volume":"12","author":"N Papadimitriou","year":"2021","unstructured":"Papadimitriou N, Markozannes G, Kanellopoulou A, Critselis E, Alhardan S, Karafousia V, et al. An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 2021;12:4579. https:\/\/doi.org\/10.1038\/s41467-021-24861-8.","journal-title":"Nat Commun"},{"key":"4441_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"issue":"8","key":"4441_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archgenpsychiatry.2011.28","volume":"68","author":"JPA Ioannidis","year":"2011","unstructured":"Ioannidis JPA. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011;68:773. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.28.","journal-title":"Arch Gen Psychiatry"},{"key":"4441_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","volume":"67","author":"D Pieper","year":"2014","unstructured":"Pieper D, Antoine S-L, Mathes T, Neugebauer EAM, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67:368\u201375. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.11.007.","journal-title":"J Clin Epidemiol"},{"key":"4441_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jrsm.1390","volume":"11","author":"EA Hennessy","year":"2020","unstructured":"Hennessy EA, Johnson BT. Examining overlap of included studies in meta-reviews: guidance for using the corrected covered area index. Res Synth Methods. 2020;11:134\u201345. https:\/\/doi.org\/10.1002\/jrsm.1390.","journal-title":"Res Synth Methods"},{"key":"4441_CR21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17195-y","author":"L-M Cao","year":"2025","unstructured":"Cao L-M, Yu Y-F, Li Z-Z, Wang G-R, Xiao Y, Luo H-Y, et al. Neoadjuvant chemoimmunotherapy for resectable head and neck squamous cell carcinoma: systematic review and meta-analysis. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-17195-y.","journal-title":"Ann Surg Oncol"},{"key":"4441_CR22","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2018.1645","author":"P Gao","year":"2018","unstructured":"Gao P, Gong L, Wang X. Induction chemotherapy in patients with resectable laryngeal cancer: a meta-analysis. Mol Clin Oncol. 2018. https:\/\/doi.org\/10.3892\/mco.2018.1645.","journal-title":"Mol Clin Oncol"},{"key":"4441_CR23","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1245\/s10434-024-16587-w","volume":"32","author":"W Widjaja","year":"2025","unstructured":"Widjaja W, Ng I, Shannon N, Iyer NG. Neoadjuvant immunotherapy in resectable HNSCC: an updated systematic review and meta-analysis. Ann Surg Oncol. 2025;32:2713\u201324. https:\/\/doi.org\/10.1245\/s10434-024-16587-w.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"4441_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoto.2021.2191","volume":"147","author":"R Masarwy","year":"2021","unstructured":"Masarwy R, Kampel L, Horowitz G, Gutfeld O, Muhanna N. Neoadjuvant PD-1\/PD-L1 inhibitors for resectable head and neck cancer: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021;147:871. https:\/\/doi.org\/10.1001\/jamaoto.2021.2191.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"4441_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.oraloncology.2019.06.001","volume":"95","author":"E Dauzier","year":"2019","unstructured":"Dauzier E, Lacas B, Blanchard P, Le Q-T, Simon C, Wolf G, et al. Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: a subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer. Oral Oncol. 2019;95:106\u201314. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.001.","journal-title":"Oral Oncol"},{"key":"4441_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.oraloncology.2016.08.022","volume":"61","author":"A Lau","year":"2016","unstructured":"Lau A, Li K-Y, Yang W, Su Y-X. Induction chemotherapy for squamous cell carcinomas of the oral cavity: a cumulative meta-analysis. Oral Oncol. 2016;61:104\u201314. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.08.022.","journal-title":"Oral Oncol"},{"issue":"15_suppl","key":"4441_CR27","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1200\/JCO.2021.39.15_suppl.6000","volume":"39","author":"L Zhang","year":"2021","unstructured":"Zhang L, Yang Y, Qu S, Li J-G, Hu C, Xu M, et al. Camrelizumab versus placebo combined with gemcitabine and cisplatin for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind, phase 3 trial. J Clin Oncol. 2021;39(15_suppl):6000\u20136000. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.6000.","journal-title":"J Clin Oncol"},{"key":"4441_CR28","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.athoracsur.2021.12.063","volume":"115","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Liang M, Zhuang X, Liu M, Fu G, Liu Q, et al. Long-term outcomes after on-pump vs off-pump coronary artery bypass grafting for ischemic cardiomyopathy. Ann Thorac Surg. 2023;115:1421\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.12.063.","journal-title":"Ann Thorac Surg"},{"key":"4441_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van Den Berg JG, Aalbers AG, Sikorska K, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26:566\u201376. https:\/\/doi.org\/10.1038\/s41591-020-0805-8.","journal-title":"Nat Med"},{"key":"4441_CR30","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/nejmoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, Van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695\u2013704. https:\/\/doi.org\/10.1056\/nejmoa071028.","journal-title":"N Engl J Med"},{"key":"4441_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/nejmoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705\u201315. https:\/\/doi.org\/10.1056\/nejmoa070956.","journal-title":"N Engl J Med"},{"key":"4441_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41416-024-02887-1","volume":"132","author":"B Jayathilaka","year":"2025","unstructured":"Jayathilaka B, Mian F, Franchini F, Au-Yeung G, IJzerman M. Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review. Br J Cancer. 2025;132:51\u20137. https:\/\/doi.org\/10.1038\/s41416-024-02887-1.","journal-title":"Br J Cancer"},{"issue":"10","key":"4441_CR33","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jamaoncol.2020.2955","volume":"6","author":"JD Schoenfeld","year":"2020","unstructured":"Schoenfeld JD, Hanna GJ, Jo VY, Rawal B, Chen Y-H, Catalano PS, et al. Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial. JAMA Oncol. 2020;6:1563. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2955.","journal-title":"JAMA Oncol"},{"key":"4441_CR34","doi-asserted-by":"publisher","first-page":"v628","DOI":"10.1093\/annonc\/mdx440.041","volume":"28","author":"RL Ferris","year":"2017","unstructured":"Ferris RL, Gon\u00e7alves A, Baxi SS, Martens UM, Gauthier H, Langenberg M, et al. An open-label, multicohort, phase 1\/2 study in patients with virus-associated cancers (CheckMate 358): safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol. 2017;28:v628\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdx440.041.","journal-title":"Ann Oncol"},{"key":"4441_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.20517\/cdr.2022.141","volume":"6","author":"S Benavente","year":"2023","unstructured":"Benavente S. Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer. Cancer Drug Resist. 2023;6:291\u2013313. https:\/\/doi.org\/10.20517\/cdr.2022.141.","journal-title":"Cancer Drug Resist"},{"key":"4441_CR36","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5534","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang S, Wan L, Ling W, Chen H, Wang J. New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (review). Int J Oncol. 2023. https:\/\/doi.org\/10.3892\/ijo.2023.5534.","journal-title":"Int J Oncol"},{"key":"4441_CR37","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1158\/1078-0432.CCR-22-0666","volume":"28","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wu B, Peng G, Xiao G, Huang J, Ding Q, et al. Neoadjuvant chemoimmunotherapy for the treatment of locally advanced head and neck squamous cell carcinoma: a single-arm phase 2 clinical trial. Clin Cancer Res. 2022;28:3268\u201376. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0666.","journal-title":"Clin Cancer Res"},{"key":"4441_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","volume":"156","author":"B Lacas","year":"2021","unstructured":"Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC group. Radiother Oncol. 2021;156:281\u201393. https:\/\/doi.org\/10.1016\/j.radonc.2021.01.013.","journal-title":"Radiother Oncol"},{"key":"4441_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1269863","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Zheng Z, Zhang Y, Bian C, Bao J, Xin Y, et al. Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis. Front Pharmacol. 2023;14:1269863. https:\/\/doi.org\/10.3389\/fphar.2023.1269863.","journal-title":"Front Pharmacol"},{"key":"4441_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejca.2021.03.025","volume":"150","author":"HH Yoon","year":"2021","unstructured":"Yoon HH, Ou F-S, Soori GS, Shi Q, Wigle DA, Sticca RP, et al. Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [alliance]). Eur J Cancer. 2021;150:214\u201323. https:\/\/doi.org\/10.1016\/j.ejca.2021.03.025.","journal-title":"Eur J Cancer"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04441-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:32:02Z","timestamp":1762338722000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04441-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4441"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04441-z","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this study is a systematic review of published literature and does not involve human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"610"}}